In March, the 22nd China International Exhibition on In Vitro Diagnostics and Blood Transfusion Instruments & Reagents (CACLP), together with the 5th China IVD Raw Materials & Supply Chain Expo (CISCE), opened as scheduled on March 22, 2025, at the Hangzhou International Expo Center. The event gathered over a thousand enterprises, covering the entire upstream and downstream IVD industry chain.

As a national high-tech enterprise engaged in the R&D, production, sales, and service of in vitro diagnostic reagents, Xinke Medical made a strong appearance with its latest innovations and upgraded product lines. Exhibits included hematology analyzer reagents, chemiluminescence immunoassay buffers, cleaning solutions, substrates, large biochemical electrolyte module reagents, as well as cleaning solutions for biochemical and coagulation analyzers.

On the first day, the Xinke booth drew huge crowds. Visitors included distributors, medical institutions, and partners from more than 20 countries and regions worldwide, such as Europe, the U.S., and Southeast Asia. Alongside long-term partners who have collaborated for over a decade, Xinke also welcomed representatives from several major medical groups in the Middle East for the first time. The sales team provided one-on-one product solutions to visitors at the booth.

With over 20 years of expertise in IVD reagent manufacturing, Xinke Medical not only delivers high-quality and cost-effective reagents but also offers value-added services with dedicated after-sales support. Having participated in CACLP for many years, Xinke continues to stay in step with industry trends, focusing on niche areas, driving continuous product upgrades, and striving to provide customers with superior quality and attentive service.